U.S. Online Retail and Ecommerce Stock News

Progyny, Inc. recently reported stronger-than-expected second quarter results and raised its full-year 2025 revenue and earnings guidance, projecting annual revenue of US$1.24 billion to US$1.27 billion and net income of US$52.3 million to US$58.9 million. Excluding the impact of a transitioning large client, the company's outlook highlights robust underlying growth, driven by expanding demand for its fertility and women’s health benefits. We'll explore how Progyny's upgraded guidance,...

Enovis Corporation recently reported its second quarter 2025 results, showing sales of US$564.55 million and a net loss of US$36.74 million, and raised its full-year 2025 revenue guidance to between US$2.245 billion and US$2.275 billion. Despite widening losses, management's decision to lift revenue expectations suggests increased confidence in the company's ability to grow sales in the current year. We'll examine how Enovis's raised revenue outlook, despite ongoing net losses, may affect...

Earlier this month, Superluminal Medicines announced a multi-billion dollar collaboration with Eli Lilly to develop AI-driven small molecule drugs for cardiometabolic diseases and obesity, while Lilly confirmed a price increase for its diabetes drug Mounjaro in the UK and reported significant insider executive share purchases. This series of developments highlights Eli Lilly's ongoing efforts to strengthen its leadership in obesity therapeutics through advanced research, proactive pricing...

In early August 2025, Mirum Pharmaceuticals reported its second quarter and six-month results, highlighting year-over-year revenue growth to US$127.79 million for the quarter and a narrowed net loss of US$5.86 million, alongside raising its full-year 2025 revenue guidance to between US$490 million and US$510 million; it also filed a new US$200 million shelf registration covering common and preferred stock, debt securities, and warrants. The improved guidance and earnings results suggest that...

Earlier this month, HealthEquity reported stronger-than-expected results for the first quarter of fiscal 2026, supported by robust growth in revenue and Health Savings Accounts alongside improvements in profitability. The company’s adoption of AI-driven claims adjudication and the rollout of new digital features have improved efficiency and strengthened member engagement, though data security threats remain a significant risk. We’ll explore how HealthEquity’s enhanced digital capabilities...

FIGS, Inc. recently reported its second quarter 2025 earnings, showing sales of US$152.64 million and net income of US$7.1 million, both higher compared to the same period last year. Alongside these results, FIGS updated its outlook for full-year 2025, now expecting net revenue growth in the low-single-digits compared to 2024, indicating cautious optimism despite ongoing industry headwinds. We'll explore how this improvement in both quarterly earnings and forward revenue guidance shapes the...

Spirit Electronics recently announced it has added Vicor Corporation to its portfolio, offering Vicor's Factorized Power Architecture (FPA) radiation-tolerant DC-DC converters for satellite and space applications. This partnership positions Vicor’s technology at the forefront of supplying advanced, radiation-resilient power delivery solutions increasingly sought after in modern, data-intensive satellite missions and space operations. We'll examine how Spirit Electronics offering Vicor’s...

Universal Corporation recently reported first quarter earnings for the period ended June 30, 2025, showing sales of US$593.76 million and net income of US$8.5 million, along with board changes and a reaffirmed quarterly dividend of US$0.82 per share. Despite a slight dip in sales compared to last year, the company posted a very large increase in net income and earnings per share from continuing operations, marking a significant turnaround in profitability. We'll examine how the substantial...

Verra Mobility Corporation recently reported its second quarter results, showing revenue of US$236.03 million and net income of US$38.58 million, and reaffirmed its 2025 revenue guidance of US$925 million to US$935 million. The company also announced a US$100 million share repurchase program, highlighting a focus on capital return initiatives alongside ongoing business growth. We’ll examine how the new share repurchase program may impact Verra Mobility’s investment narrative and future...

On August 5, 2025, PyroGenesis Inc. announced it signed an additional contract with Constellium to implement plasma torch technology in an aluminum remelting furnace, marking the start of Phase 2 in their joint decarbonization project. This latest step highlights Constellium's focus on adopting advanced electrification technology to reduce emissions and improve energy efficiency in aluminum processing. Let's explore how this commitment to plasma-based electrification could impact...

Doximity, Inc. recently announced its first quarter results for the period ended June 30, 2025, reporting sales of US$145.91 million and net income of US$53.32 million, alongside issuing revenue guidance of US$157 million to US$158 million for the second quarter and US$628 million to US$636 million for the fiscal year ending March 31, 2026. The completion of a substantial share buyback, over 4.14 million shares valued at nearly US$200 million, reflects ongoing efforts to return capital to...

Icahn Enterprises recently completed a US$500 million senior secured notes offering due 2029 and reported second-quarter 2025 earnings, which included a narrower quarterly net loss year-over-year and the affirmation of its quarterly distribution. This combination of debt financing and financial results highlights the company’s efforts to manage its capital structure while continuing regular distributions despite ongoing net losses. We'll explore how the recent senior notes issuance shapes...

On August 5, 2025, Organon & Co. raised its full-year 2025 earnings and revenue guidance, now expecting revenue between US$6.28 billion and US$6.38 billion, following the release of second-quarter results that showed both sales and earnings declined compared to the previous year. The company's updated outlook indicates management foresees business improvement ahead despite recent declines, offering fresh insight into expectations for the rest of the year. We'll explore how Organon's raised...

IAC Inc. recently reported a turnaround to US$211.45 million in net income for the second quarter of 2025, completed a US$450.96 million share buyback program, and outlined ongoing pursuit of M&A opportunities while presenting at the Oppenheimer Annual Technology, Internet & Communications Conference. Despite a year-over-year decrease in sales, IAC achieved positive earnings and continued to actively allocate capital and seek growth avenues through acquisitions. Next, we'll explore how IAC's...

Earlier this month, Tyson Foods expanded its share buyback program by an additional 43 million shares, declared quarterly dividends for both Class A and B shares, and appointed Xbox President Sarah Bond as a new independent director following its third-quarter financial results and a reported $343 million goodwill impairment. The addition of a technology executive to Tyson’s board and continuation of shareholder returns underscore the company’s focus on board diversification and capital...

AIS Healthcare recently announced it has secured a group purchasing agreement with Premier Inc. for 503A intrathecal compounded medications, effective since July 1, 2025. This agreement not only grants Premier members access to pre-negotiated pricing on specialized medications, but also introduces ongoing quality reporting and site audit support, potentially elevating compliance and supply chain standards for participating hospitals. We'll explore how access to specialized compounded...

Zimmer Biomet Holdings reported second-quarter 2025 results showing sales of US$2,077.3 million, up from US$1,942 million a year earlier, while net income fell to US$152.8 million from US$242.8 million. Alongside these results, the company raised its full-year revenue guidance, narrowing the expected growth range and increasing the minimum growth outlook for 2025. With the updated revenue guidance signaling stronger baseline expectations, we'll explore how this adjustment shapes Zimmer...

Tempus AI (TEM) has posted an impressive price move of 21% over the last week, likely influenced by a blend of recent developments. The company announced significant revenue growth in its second quarter results and notably reduced its net loss. This positive financial performance was reinforced by the raised full-year revenue guidance, although it accompanies challenges such as a class action lawsuit and a substantial equity offering. The broader market has also been on an upward trajectory,...

NYSE:APO 1 Year Share Price vs Fair Value Explore Apollo Global Management's Fair Values from the Community and select...

NasdaqGM:CRML 1 Year Share Price vs Fair Value Explore Critical Metals's Fair Values from the Community and select...

NasdaqGS:INSM 1 Year Share Price vs Fair Value Explore Insmed's Fair Values from the Community and select yours We...

Most readers would already be aware that Ollie's Bargain Outlet Holdings' (NASDAQ:OLLI) stock increased significantly...

Five Below's (NASDAQ:FIVE) stock is up by a considerable 24% over the past three months. Given that the market rewards...

NasdaqGS:BGC 1 Year Share Price vs Fair Value Explore BGC Group's Fair Values from the Community and select yours BGC...